-
HOW INFORMATIVE ARE FRENCH HEALTH ECONOMIC EVALUATIONS FOR PRICING DECISIONS IN ONCOLOGY PRODUCTS?
Aug 11, 2026, 17:16 PM -
THE ANNUAL SOCIETAL VALUE OF CONTINUOUS VACCINATION INVESTMENT: A BENEFIT COST ANALYSIS OF ADULT IMMUNISATION PROGRAMS IN GERMANY
Aug 11, 2026, 17:16 PM -
ECONOMIC EVALUATION OF SAMD ASSISTED LDCT SURVEILLANCE UNDER DIAGNOSTIC PERFORMANCE UNCERTAINTY
Aug 11, 2026, 17:16 PM -
PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF NUVAXOVIDVSMRNA COVID-19 VACCINES IN ADULTS AGED =65 YEARS IN FRANCE
Aug 11, 2026, 17:16 PM -
DEFINITION AND ASSESSMENT OF INFANT NEURODEVELOPMENTAL DELAYS IN PREGNANCY STUDIES: AN AI-ASSISTED TARGETED LITERATURE
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF PCV20 IN ECUADOR IN PEDIATRIC POPULATION: A HEALTHCARE SYSTEM PERSPECTIVE ANALYSIS
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF FLUID OVERLOAD IN MAINTENANCE HEMODIALYSIS PATIENTS IN FRANCE, GERMANY, AND ITALY
Aug 11, 2026, 17:16 PM -
LARGE LANGUAGE MODEL-ENABLED MEDICAL CONSULTATION IN CHINA: A DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION IN THE BRAZILIAN PUBLIC HEALTHCARE: A DATABASE STUDY
Aug 11, 2026, 17:16 PM -
TEMPORAL DYNAMICS, PANDEMIC DISRUPTION AND FORECASTING OF DAY SURGERY CASES IN HUNGARY FOR 2030
Aug 11, 2026, 17:16 PM -
BALANCING SUBSTITUTION AND INITIATION THROUGH A MODELING FRAMEWORK TO ASSESS THE POPULATION HEALTH IMPACT OF ELECTRONIC VAPOUR PRODUCTS
Aug 11, 2026, 17:16 PM -
LATENT SIMILARITY MATCHING FOR EXTERNAL CONTROL ARMS: A PREREGISTERED TARGET TRIAL EMULATION REPRODUCING A RANDOMIZED SPINAL CORD INJURY PLACEBO ARM
Aug 11, 2026, 17:16 PM -
HIDDEN ECONOMIC BURDEN OF THYROID EYE DISEASE: A SYSTEMATIC REVIEW OF COSTS FROM A SOCIETAL PERSPECTIVE
Aug 11, 2026, 17:16 PM -
VALUING HIDDEN INPUTS TO HOSPITAL CARE: WILLINGNESS TO PAY AND WILLINGNESS TO ACCEPT COMPENSATION FOR INFORMAL INPATIENT CAREGIVING IN CHINA
Aug 11, 2026, 17:16 PM -
TIPPING POINT QUANTITATIVE BIAS ANALYSIS APPROACHES TO POPULATION-ADJUSTED INDIRECT COMPARISONS WITH INCOMPLETE DATA
Aug 11, 2026, 17:16 PM -
REAL-WORLD FARICIMAB DOSING INTERVALS DIABETIC MACULAR EDEMA: IMPACT ON HEALTHCARE RESOURCE USE, COSTS, AND TRAVEL-RELATED CARBON EMISSIONS
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF ORAL BISPHOSPHONATES FOR OSTEOPENIA IN SINGAPORE: IMPLICATIONS FOR RISK-BASED INTERVENTION THRESHOLDS
Aug 11, 2026, 17:16 PM -
PATIENT-PHYSICIAN DIFFERENCES IN PREFERENCES FOR FINANCIAL INCENTIVES TO IMPROVE MEDICATION ADHERENCE: EVIDENCE FROM A BEST-WORST SCALING STUDY IN CHINA
Aug 11, 2026, 17:16 PM -
BUDGET IMPACT ANALYSIS OF FITUSIRAN FOR THE TREATMENT OF HEMOPHILIA A AND B IN PEDIATRIC AND ADULT PATIENTS IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
UNDERSTANDING UNMET NEED IN THE CONTEMPORARY TREATMENT LANDSCAPE IN A EUROPEAN GENERALIZED MYASTHENIA GRAVIS POPULATION FROM BOTH PHYSICIAN AND PATIENT PERSPECTIVES: A REAL-WORLD STUDY
Aug 11, 2026, 17:16 PM
